Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy

BACKGROUND: Advanced non‐small cell lung cancer (NSCLC) accounts for a high proportion of lung cancer cases. Targeted therapy improve the survival in these patients, but acquired drug resistance will inevitably occur. If tumor downstaging is achieved after targeted therapy, could surgical resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kuo, Cao, Xiaonian, Ai, Bo, Xiao, Han, Huang, Quanfu, Zhang, Zheng, Chu, Qian, Zhang, Li, Dai, Xiaofang, Liao, Yongde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327695/
https://www.ncbi.nlm.nih.gov/pubmed/34128318
http://dx.doi.org/10.1111/1759-7714.14044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327695/
https://www.ncbi.nlm.nih.gov/pubmed/34128318
http://dx.doi.org/10.1111/1759-7714.14044

Ejemplares similares